Table 2.
Clinical characteristics of 35 patients.
| Clinical characteristics | Patients (n = 35) |
|---|---|
| Demographics characteristics | |
| Age, median (IQR), years. Male, sex, No. (%) |
62 (50.0–84.0) 20 (57.1) |
| Times of contact with Case A, median (IQR), days Protopathy, No. (%) |
4 (1.0–6.0) |
| Cardiovascular disease | 9 (25.7) |
| Digestive diseases | 8 (22.9) |
| Cerebrovascular disease | 5 (14.3) |
| Orthopedic disease | 4 (11.4) |
| Hematological disease Renal disease Cancer |
2 (5.7) 2 (5.7) 3 (8.6) |
| Others1 | 2 (5.7) |
| Respiratory symptoms | |
| None, No. (%) Any, No. (%) Fever Newly emerged fever |
16 (45.7) 19 (54.3) 11 (31.4) 7 (20.0) |
| Cough | 8 (22.9) |
| Sputum | 4 (11.4) |
| Dyspnea | 7 (20.0) |
| Newly emerged dyspnea | 1 (2.9) |
| Laboratory findings | |
| Leukocyte count ( × 109/L, normal range 4.0–10.0), No. (%) | |
| Increased Decreased Normal |
14 (40.0) 3 (8.6) 18 (51.4) |
| Lymphocyte count ( × 109/L, normal range 1.5–3.5), No. (%) | |
| Increased Decreased Normal |
1 (2.9) 12 (34.3) 22 (62.9) |
| Nucleic acid test negative, No. (%) | 35 (100.0) |
| Radiologic findings | |
| Normal on chest CT, No. (%) | 11 (31.4) |
| Abnormalities on chest CT, No. (%) | 24 (68.6) |
| Inflammatory change | 12 (34.3) |
| Pleural effusion | 16 (45.7) |
| Interstitial change Pulmonary edema |
2 (5.7) 1 (2.9) |
| Pulmonary nodule | 1 (2.9) |
| Clinical outcome | |
| Transfer to specialized department, No. (%) | 25 (71.4) |
| Discharge from hospital, No. (%) | 8 (22.9) |
| Death, No. (%) | 2 (5.7) |
1
Others include urologic diseases and rheumatic disease.